Ind-Swift Laboratories Ltd Share Price

Pharmaceuticals

NSE: INDSWFTLAB Small Cap ISIN: INE915B01019

As on 13 June 2026 at 01:09 IST

₹161.92

+ 3.29

(2.07%)

Sell Buy

Over 1 Month

14.50%

Over 6 Months

65.67%

Over 1 Year

43.86%

Over 3 Years

127.43%

Ind-Swift Laboratories Ltd Summary

Close ₹158.63

Open ₹162.28

High ₹164.80

Low ₹158

Volume 5,66,933

Net Turnover (in Cr) ₹9.1

52Wk High ₹173.25

52Wk Low ₹87.15

52Wk High / Low

87.15

173.25

Ind-Swift Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,379.47

EPS (TTM) 5.83

Book Value (BV) 157.64

Div. Yield -

P/E (TTM) 32.38

Price/Book Value 1

Delivery % 51.59 %

Face Value 10

Key Ratios

PE Ratio 2.25

PB Ratio 0.53

EV to Sales 0.22

PEG Ratio -0.04

ROA 20.99

ROE 0.64

Debt-Equity 0.11

Net Profit Margin 1.46

Operating Profit Margin 7.21

Ind-Swift Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	643.09	1,797.50	1,240.81	1,082.23	914.04
Total Expenses	608.50	1,590.28	1,127.64	1,069.70	896.03
Profit Before Tax	257.80	598.22	86.52	12.53	18.01
Profit After Tax	250.53	539.24	47.83	-2.15	-3.15
Operating Profit After Depreciation	37.51	311	205.34	108.08	118.23

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	270.75	189.41	585.04	628.53	746.80
Total Non Current Assets	572.99	500.97	659.55	725.46	874.27
Total Current Assets	865.35	959.46	1,164.52	1,075.33	944.18
Total Assets	1,438.34	1,460.43	1,824.06	1,800.79	1,818.45
Total Shareholder's Fund	1,173	812.08	681.93	600.97	603.51

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-25.47	-186.98	194.62	150.27	134.95
Net Cash Used In Investing Activities	-110.20	-27.60	-13.37	4.77	-10.17
Net Cash Used In Financing Activities	69.20	657.35	-185.66	-140.88	-123.75

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	630.92	1,760.86	1,185.24	1,030.59	879.71
Total Expenses	589.98	1,557.92	1,079.39	1,020.90	863.59
Profit Before Tax	264.14	593.93	79.20	8	16.12
Profit After Tax	256.09	536.18	42.47	-5.71	-4.40
Operating Profit After Depreciation	43.86	306.70	198.01	105.23	116.33

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	270.71	189.37	585	627.79	745.78
Total Non Current Assets	628.32	556.24	714.20	804.75	951.39
Total Current Assets	793.73	852.16	1,074.07	998.16	865.80
Total Assets	1,422.05	1,408.40	1,788.27	1,802.91	1,817.20
Total Shareholder's Fund	1,164.08	798.15	675.35	632.56	638.69

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-39.15	-165.74	182.67	136.26	135.03
Net Cash Used In Investing Activities	-109.67	-27.71	-13.69	2.76	-10.17
Net Cash Used In Financing Activities	74.22	657.78	-168.41	-139.59	-123.75

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	169.79	150.85	152.64	152.73	138.24
Total Expenses	149.21	146.67	151.17	149.13	147.43
Profit Before Tax	11.96	16.40	10.34	10.35	230.47
Profit After Tax	15.11	9.52	8.04	8.65	222.27
Operating Profit after Depreciation	22.80	31.76	19.33	18.18	-4.73

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	172.70	153.17	150.44	147.99	149.52
Total Expenses	152.39	144.08	148.24	144.92	158.21
Profit Before Tax	11.73	17.62	11.07	9.82	226.15
Profit After Tax	14.94	10.74	8.76	8.12	218.09
Operating Profit after Depreciation	22.52	32.98	20.06	17.65	-9.05

Ind-Swift Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 156.15

S2 153.68

S3 149.35

Pivot 160.48

R1 162.95

R2 167.28

R3 169.75

Moving Average

20 SMA 146.60

50 SMA 142.31

100 SMA 136.06

200 SMA 117.48

Ind-Swift Laboratories Ltd Corporate Actions

No available data

AGM Date: 30 Sep 2021

Ind-Swift Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 26 2021 to September 30 2021 (both days inclusive) for the purpose of 26th Annual General Meeting (AGM) of the Company to be held on September 30 2021. Proceeding of 26th Annual General Meeting of the Company held on 30th September 2021 through VC/OAVM (As Per BSE Announcement Dated on 9/30/2021 6:07:04 AM) Voting Results along with the Scrutinizer''s Report with respect to 26' Annual General Meeting of Ind Swift Laboratories Limited (As Per BSE announcement Dated on 01.10.2021) Revised Voting Results along with the Scrutinizers Report w.r.t to 26th AGM of Ind Swift Laboratories Limited(As Per BSE Announcement Dated on 10/7/2021 4:59:28 AM)

AGM Date: 30 Sep 2022

AGM 30/09/2022 Outcome of the Board Meeting-10.08.2022 (As Per BSE Announcement dated on 10.08.2022) Proceedings of 27th Annual General Meeting of the Company held through Video Conferencing/Other Audio-Visual Means Re-appointment of Statutory Auditors (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 30 Sep 2023

AGM 30/09/2023 Outcome of Board Meeting held on 31st August, 2023 (As Per BSE Announcement dated on 31.08.2023) Notice of 28th AGM (As Per BSE Announcement Dated on 07/09/2023)

AGM Date: 30 Sep 2024

AGM 30/09/2024 Please refer attached pdf. (As Per BSE Announcement dated on 28.08.2024) Please refer attached pdf. (As Per Bse Announcement Dated on 30.09.2024)

AGM Date: 29 Sep 2025

To convene the 30th Annual General Meeting (AGM) of the Members of the Company on Monday, the 29th day of September, 2025 at 11:30 A.M. through Video Conferencing (VC) or Other Audio- Visual Means (OAVM). The Cut-off date for the purpose of ascertaining members entitled for remote e-voting and eligible to participate in ensuing AGM is i.e., Monday, 22nd September, 2025. Proceedings of 30th AGM of Ind Swift Laboratories Limited held on Monday, 29th September, 2025 at 11:30 A.M. The members of the Company at the 30th AGM held on 29-09-2025, considered and approved the resolutions as per attached pdf. (As Per BSE Announcement Dated on 29.09.2025) Scrutinizer''s report and voting results for the 30th AGM held on 29-09-2025 is enclosed herewith (As per BSE Announcement dated on: 01.10.2025)

Ind-Swift Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Ind-Swift Laboratories Ltd Top Mutal Funds Invested

No data available

Ind-Swift Laboratories Ltd News

Ind-Swift Laboratories to table results

On 28 May 2026

23 May 2026, 05:13 pm

Ind-Swift Laboratories to conduct board meeting

On 31 January 2026

29 Jan 2026, 11:03 am

Ind-Swift Laboratories to announce Quarterly Result

On 14 November 2025

08 Nov 2025, 01:39 pm

Ind-Swift Laboratories to convene AGM

On 29 September 2025

28 Aug 2025, 10:06 am

Ind-Swift Laboratories announces board meeting date

On 13 August 2025

02 Aug 2025, 05:15 pm

Ind-Swift Laboratories Ltd Stock Analysis

Annual revenue for Ind-Swift Laboratories Ltd decreased by 64.17% to ₹630.92 crore in FY 2025 from ₹1,760.86 crore in FY 2024.
Annual Net Profit for Ind-Swift Laboratories Ltd decreased by 52.24% to ₹256.09 crore in FY 2025 from ₹536.18 crore in FY 2024.
Promoter Shareholding in Ind-Swift Laboratories Ltd decreased by 0.14% in the most recent quarter, from 43.06% in February 2026 to 42.99% in March 2026.
Ind-Swift Laboratories Ltd delivered a 1-year return of 43.86% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Ind-Swift Laboratories Ltd share price moved up by 2.07% from its previous close of INR ₹158.63. The latest Ind-Swift Laboratories Ltd share price is INR ₹161.92.
Ind-Swift Laboratories Ltd share price today has been at a low of 160 and a high of 162.50. Over the past 52 weeks, the Ind-Swift Laboratories Ltd share price has seen a low of 87.15 and a high of 173.25.